A Study of Telemonitoring in Cancer Patients

Number of all telephone calls during the first 4 months of oral or intravenous cancer treatment

The goal of this prospective, randomized, unblinded, single-centre, interventional study is
 to assess the effectiveness of standard of care with Cureety, compared to standard of care
 alone, to reduce the number of all telephone calls during the first 4 months of oral or
 intravenous cancer treatment for patients older than 18 years of age, initiating oral or
 intravenous cancer treatment at the Centre Hospitalier de Bligny.
 
 Patients initiating either oral or intravenous chemotherapy for cancer will be randomly
 allocated in a 1:1 ratio to either:
 
 - In-person care alone (Standard of care group).
 
 - In-person care with Cureety telemonitoring (Standard of care with Cureety group).
 
 Participants will:
 
 - be monitored with digital application Cureety (Standard of care with Cureety group)
 
 - fill out quality of life questionnaire (baseline, 2 months, 4 months)
 
 - fill out satisfaction questionnaire (2 months, 4 months)
 
 - have the ongoing and incoming phone calls logged (duration and type)